DURAMINE
Turnover is estimated at about €290,000, probably between €220,000 and €350,000. The micro format does not state turnover.
Balance sheet
balance sheet total €1.2m on 31-12-2025in euro
in euro
Position in the sector
16.8%
Higher than 18% of the 21,373 companies filing micro accounts in human health (NACE 86) in 2025.
0.82
Higher than 13% of the 20,922 companies filing micro accounts in human health (NACE 86) in 2025.
2.3%
Higher than 11% of the 21,223 companies filing micro accounts in human health (NACE 86) in 2025.
Net result: middle half · Equity: middle half · Balance sheet total: top quarter · Working capital: bottom quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 202014 months |
|---|---|---|---|---|---|---|---|
| 92,906 | 154,826 | 132,286 | 100,363 | 89,535 | 62,299 | ||
| 69,527 | 114,828 | 100,901 | 78,919 | 72,566 | 50,654 | ||
| 526,781 | 233,568 | 290,000 | 1,599 | 6,390 | 24,500 | ||
| -2,859 | -57,092 | 59,513 | -31,197 | 15,945 | - | ||
| -37,346 | 26,641 | 81,997 | 171,049 | 94,529 | 29,154 | ||
| 16.8% | 31.6% | 16.6% | 82.9% | 85.5% | 78.9% | ||
| 0.82 | 1.33 | 1.40 | 5.57 | 6.03 | 3.45 | ||
| 0.59 | 0.76 | 1.15 | 3.56 | 6.03 | 3.45 | ||
| 4.94 | 2.16 | 5.04 | 0.21 | 0.17 | 0.27 | ||
| 13.7% | 51.6% | 96.7% | 39.6% | 60.3% | 93.3% | ||
| 2.3% | 16.3% | 16.0% | 32.8% | 51.5% | 73.6% | ||
| 3.83 | 12.91 | 27.83 | over 100 | over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 202014 months |
|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||
20/58 |
1.2m | 618,775 | 576,902 | 218,932 | 129,258 | 56,607 | |
21/28 |
995,690 | 511,569 | 291,870 | 10,425 | 15,935 | 15,538 | |
22/27 |
995,690 | 511,569 | 291,870 | 10,425 | 15,935 | 15,538 | |
22 |
883,809 | 452,512 | 285,904 | - | - | - | |
23 |
73,975 | 54,564 | - | - | - | - | |
24 |
37,905 | 4,494 | 5,965 | 10,425 | 15,935 | 15,538 | |
29/58 |
166,735 | 107,205 | 285,032 | 208,507 | 113,323 | 41,070 | |
3 |
46,336 | 46,336 | 51,270 | 75,207 | - | - | |
30/36 |
46,336 | 46,336 | 51,270 | 75,207 | - | - | |
40/41 |
104,958 | 22,599 | 130,129 | 109,357 | 47,535 | 7,086 | |
40 |
72,884 | 10,000 | 636 | - | 81 | 3,100 | |
41 |
32,074 | 12,599 | 129,493 | 109,357 | 47,454 | 3,986 | |
54/58 |
12,962 | 15,820 | 72,912 | 13,399 | 44,596 | 28,651 | |
490/1 |
2,479 | 22,449 | 30,720 | 10,544 | 21,192 | 5,333 | |
| Balance sheet: equity and liabilities | |||||||
10/49 |
1.2m | 618,775 | 576,902 | 218,932 | 129,258 | 56,607 | |
10/15 |
195,621 | 195,621 | 95,520 | 181,474 | 110,464 | 44,691 | |
10/11 |
3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | |
14 |
192,621 | 192,621 | 92,520 | 178,474 | 107,464 | 41,691 | |
17/49 |
966,803 | 423,154 | 481,382 | 37,458 | 18,794 | 11,916 | |
17 |
762,723 | 342,590 | 278,347 | - | - | - | |
170/4 |
762,723 | 342,590 | 278,347 | - | - | - | |
42/48 |
204,081 | 80,564 | 203,035 | 37,458 | 18,794 | 11,916 | |
42 |
57,880 | 10,757 | 15,414 | - | - | - | |
44 |
94,785 | 68,548 | 2,833 | 19,668 | 45 | 713 | |
440/4 |
94,785 | 68,548 | 2,833 | 19,668 | 45 | 713 | |
45 |
375 | 400 | 6,488 | 16,990 | 17,949 | 11,204 | |
450/3 |
375 | 400 | 6,488 | 16,990 | 17,949 | 11,204 | |
47/48 |
51,041 | 859 | 178,300 | 800 | 800 | - | |
| Income statement | |||||||
9900 |
124,007 | 163,047 | 172,538 | 100,960 | 89,780 | 62,654 | |
62 |
29,255 | - | - | - | - | - | |
630 |
42,661 | 13,868 | 8,555 | 7,109 | 5,993 | 8,963 | |
640/8 |
1,846 | 8,221 | 40,252 | 596 | 245 | 355 | |
9901 |
50,246 | 140,958 | 123,731 | 93,254 | 83,543 | 53,336 | |
75/76B |
- | 4,023 | 6,587 | 5,598 | 1,667 | 203 | |
75 |
- | 4,023 | 6,587 | 5,598 | 1,667 | 203 | |
65/66B |
24,244 | 11,993 | 4,753 | 52 | 424 | 645 | |
65 |
24,244 | 11,993 | 4,753 | 52 | 424 | 645 | |
9903 |
26,001 | 132,987 | 125,564 | 98,800 | 84,785 | 52,895 | |
67/77 |
-865 | 32,028 | 33,218 | 26,990 | 18,212 | 11,204 | |
9904 |
26,866 | 100,960 | 92,346 | 71,810 | 66,573 | 41,691 | |
9905 |
26,866 | 100,960 | 92,346 | 71,810 | 66,573 | 41,691 | |
| Appropriation of the result | |||||||
9906 |
219,487 | 193,480 | 270,820 | 179,274 | 108,264 | 41,691 | |
14P |
192,621 | 92,520 | 178,474 | 107,464 | 41,691 | - | |
694/7 |
26,866 | 859 | 178,300 | 800 | 800 | - | |
694 |
26,866 | 859 | 178,300 | 800 | 800 | - | |
| Document | |||||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 27-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankThe accounts were filed on 27-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00449455.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 27-08-2026 | 2026-00449455 | |
| 31-12-2024 | micro format | 30-08-2025 | 2025-00456412 | |
| 31-12-2023 | micro format | 31-07-2024 | 2024-00332014 | |
| 31-12-2022 | micro format | 27-07-2023 | 2023-00308506 | |
| 31-12-2021 | micro format | 28-07-2022 | 2022-20259048 | |
| 31-12-2020 | micro format | 31-08-2021 | 2021-64600331 |
Securities and guarantees
on own assets and for others| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Mortgages, amount registered | - | - | €290,000 | - | - |
| Carrying value of the mortgaged assets | - | - | €285,904 | - | - |
Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €526,781 | €233,568 | €290,000 | €1,599 | €6,390 |
| €42,661 | €13,868 | €8,555 | €7,109 | €5,993 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on DURAMINE
The operating result for 2025 is 64% lower than in 2024 and the lowest since 2021.
Debt's share of the balance-sheet total rises from 68.4% to 83.2%. Debt is higher.